COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Nanotechnology Drug Delivery Systems will have significant change from previous year. By the most conservative estimates of global Nanotechnology Drug Delivery Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Nanotechnology Drug Delivery Systems market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Nanotechnology Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Nanotechnology Drug Delivery Systems, covering the supply chain analysis, impact assessment to the Nanotechnology Drug Delivery Systems market size growth rate in several scenarios, and the measures to be undertaken by Nanotechnology Drug Delivery Systems companies in response to the COVID-19 epidemic.
Segmentation by product type:
Nanocrystals
Nanoparticles
Dendrimers
Gold Nanoparticles
Fullerenes
Liposomes
Nanotubes
Others
Segmentation by Application
Immunology
Cardiovascular
Neurology
Oncology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
Rest of Americas
APAC
China
Japan
Korea
Taiwan
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Rest of APAC
Europe
Germany
France
UK
Russia
Italy
Benelux
Nordic
Rest of Europe
MENA
Saudi Arabia
UAE
Turkey
South Africa
Egypt
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.
AbbVie, Inc.
3M
Amgen Inc.
Johnson & Johnson
Merck & Co., Inc.
Celgene Corporation
Pfizer, Inc.
Novartis International AG
Teva Pharmaceutical Industries Ltd.
Perrigo Company plc
Nitto
TheraJect
Microdermics
Zosano Pharma
Corium
Nanopass Technologies
Lohmann Therapie-Systeme AG
Valeritas
Becton-Dickinson_BD_Technologies
Vaxxas
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Nanotechnology Drug Delivery Systems?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Nanotechnology Drug Delivery Systems Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 Market Overview
2.1.1 Global Nanotechnology Drug Delivery Systems Market Size and Forecast, 2015-2025
2.1.2 Nanotechnology Drug Delivery Systems Market Size and Forecast by Region, 2015 VS 2020 VS 2025
2.2 Global Nanotechnology Drug Delivery Systems Market Size and Forecast by Regions, 2015-2025 ($ millions)
2.3 Americas Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
2.4 APAC Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
2.5 Europe Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
2.6 MENA Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
3 Nanotechnology Drug Delivery Systems Market Size by Player
3.1 Global Nanotechnology Drug Delivery Systems Market Size by Player
3.1.1 Global Top Players Nanotechnology Drug Delivery Systems Revenue, 2018-2020E ($ millions)
3.1.2 Global Top Nanotechnology Drug Delivery Systems Players Market Share, 2018-2020E
3.2 Global Key Nanotechnology Drug Delivery Systems Players Rank in 2019
3.3 Global Key Nanotechnology Drug Delivery Systems Players Head office and Products Offered
3.4 Market Concentration Rate Analysis
3.4.1 Competition Landscape Analysis
3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
3.5 New Products and Potential Entrants
3.6 Mergers & Acquisitions, Expansion
4 Nanotechnology Drug Delivery Systems Segment by Type
4.1 Overview
4.1.1 Nanocrystals
4.1.2 Nanoparticles
4.1.3 Dendrimers
4.1.4 Gold Nanoparticles
4.1.5 Fullerenes
4.1.6 Liposomes
4.1.7 Nanotubes
4.1.8 Others
4.2 Global Nanotechnology Drug Delivery Systems Market Size by Type, 2015-2025 ($ millions)
4.3 Nanocrystals Market Size by Region, 2015-2025 ($ millions)
4.4 Nanoparticles Market Size by Region, 2015-2025 ($ millions)
4.5 Dendrimers Market Size by Region, 2015-2025 ($ millions)
4.6 Gold Nanoparticles Market Size by Region, 2015-2025 ($ millions)
4.7 Fullerenes Market Size by Region, 2015-2025 ($ millions)
4.8 Liposomes Market Size by Region, 2015-2025 ($ millions)
4.9 Nanotubes Market Size by Region, 2015-2025 ($ millions)
4.10 Others Market Size by Region, 2015-2025 ($ millions)
5 Nanotechnology Drug Delivery Systems Segment by Application
5.1 Overview
5.1.1 Immunology
5.1.2 Cardiovascular
5.1.3 Neurology
5.1.4 Oncology
5.1.5 Others
5.2 Global Nanotechnology Drug Delivery Systems Market Size by Application, 2015-2025 ($ millions)
5.3 Immunology Market Size by Region, 2015-2025 ($ millions)
5.4 Cardiovascular Market Size by Region, 2015-2025 ($ millions)
5.5 Neurology Market Size by Region, 2015-2025 ($ millions)
5.6 Oncology Market Size by Region, 2015-2025 ($ millions)
5.7 Others Market Size by Region, 2015-2025 ($ millions)
6 Americas
6.1 Americas Nanotechnology Drug Delivery Systems Market Size by Country
6.2 United States Nanotechnology Drug Delivery Systems Market Size
6.3 Canada Nanotechnology Drug Delivery Systems Market Size
6.4 Mexico Nanotechnology Drug Delivery Systems Market Size
6.5 Brazil Nanotechnology Drug Delivery Systems Market Size
7 APAC
7.1 APAC Nanotechnology Drug Delivery Systems Market Size by Regions
7.2 China Nanotechnology Drug Delivery Systems Market Size
7.3 Japan Nanotechnology Drug Delivery Systems Market Size
7.4 Korea Nanotechnology Drug Delivery Systems Market Size
7.5 Taiwan Nanotechnology Drug Delivery Systems Market Size
7.6 India Nanotechnology Drug Delivery Systems Market Size
7.7 Australia Nanotechnology Drug Delivery Systems Market Size
7.8 Indonesia Nanotechnology Drug Delivery Systems Market Size
7.9 Thailand Nanotechnology Drug Delivery Systems Market Size
7.10 Malaysia Nanotechnology Drug Delivery Systems Market Size
7.11 Philippines Nanotechnology Drug Delivery Systems Market Size
7.12 Vietnam Nanotechnology Drug Delivery Systems Market Size
8 Europe
8.1 Europe Nanotechnology Drug Delivery Systems by Country
8.2 Germany Nanotechnology Drug Delivery Systems Market Size
8.3 France Nanotechnology Drug Delivery Systems Market Size
8.4 UK Nanotechnology Drug Delivery Systems Market Size
8.5 Russia Nanotechnology Drug Delivery Systems Market Size
8.6 Italy Nanotechnology Drug Delivery Systems Market Size
8.7 Australia Nanotechnology Drug Delivery Systems Market Size
8.8 Benelux Nanotechnology Drug Delivery Systems Market Size
8.9 Nordic Nanotechnology Drug Delivery Systems Market Size
9 MENA
9.1 MENA & Africa Nanotechnology Drug Delivery Systems by Country
9.2 Saudi Arabia Nanotechnology Drug Delivery Systems Market Size
9.3 UAE Nanotechnology Drug Delivery Systems Market Size
9.4 Turkey Nanotechnology Drug Delivery Systems Market Size
9.5 South Africa Nanotechnology Drug Delivery Systems Market Size
9.6 Egypt Nanotechnology Drug Delivery Systems Market Size
10 Market Drivers, Challenges and Trends
10.1 Market Drivers and Impact
10.1.1 Growing Demand from Key Regions
10.1.2 Growing Demand from Key Applications and Potential Industries
10.2 Market Challenges and Impact
10.3 Market Trends
11 Key Players Analysis
11.1 AbbVie, Inc.
11.1.1 AbbVie, Inc. Company Information
11.1.2 AbbVie, Inc. Nanotechnology Drug Delivery Systems Product Offered
11.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.1.4 AbbVie, Inc. Main Business Overview
11.1.5 AbbVie, Inc. Latest Developments
11.2 3M
11.2.1 3M Company Information
11.2.2 3M Nanotechnology Drug Delivery Systems Product Offered
11.2.3 3M Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.2.4 3M Main Business Overview
11.2.5 3M Latest Developments
11.3 Amgen Inc.
11.3.1 Amgen Inc. Company Information
11.3.2 Amgen Inc. Nanotechnology Drug Delivery Systems Product Offered
11.3.3 Amgen Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.3.4 Amgen Inc. Main Business Overview
11.3.5 Amgen Inc. Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Nanotechnology Drug Delivery Systems Product Offered
11.4.3 Johnson & Johnson Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Information
11.5.2 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Product Offered
11.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.5.4 Merck & Co., Inc. Main Business Overview
11.5.5 Merck & Co., Inc. Latest Developments
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Information
11.6.2 Celgene Corporation Nanotechnology Drug Delivery Systems Product Offered
11.6.3 Celgene Corporation Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.6.4 Celgene Corporation Main Business Overview
11.6.5 Celgene Corporation Latest Developments
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Information
11.7.2 Pfizer, Inc. Nanotechnology Drug Delivery Systems Product Offered
11.7.3 Pfizer, Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.7.4 Pfizer, Inc. Main Business Overview
11.7.5 Pfizer, Inc. Latest Developments
11.8 Novartis International AG
11.8.1 Novartis International AG Company Information
11.8.2 Novartis International AG Nanotechnology Drug Delivery Systems Product Offered
11.8.3 Novartis International AG Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.8.4 Novartis International AG Main Business Overview
11.8.5 Novartis International AG Latest Developments
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Information
11.9.2 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Product Offered
11.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.9.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.10 Perrigo Company plc
11.10.1 Perrigo Company plc Company Information
11.10.2 Perrigo Company plc Nanotechnology Drug Delivery Systems Product Offered
11.10.3 Perrigo Company plc Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.10.4 Perrigo Company plc Main Business Overview
11.10.5 Perrigo Company plc Latest Developments
11.11 Nitto
11.11.1 Nitto Company Information
11.11.2 Nitto Nanotechnology Drug Delivery Systems Product Offered
11.11.3 Nitto Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.11.4 Nitto Main Business Overview
11.11.5 Nitto Latest Developments
11.12 TheraJect
11.12.1 TheraJect Company Information
11.12.2 TheraJect Nanotechnology Drug Delivery Systems Product Offered
11.12.3 TheraJect Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.12.4 TheraJect Main Business Overview
11.12.5 TheraJect Latest Developments
11.13 Microdermics
11.13.1 Microdermics Company Information
11.13.2 Microdermics Nanotechnology Drug Delivery Systems Product Offered
11.13.3 Microdermics Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.13.4 Microdermics Main Business Overview
11.13.5 Microdermics Latest Developments
11.14 Zosano Pharma
11.14.1 Zosano Pharma Company Information
11.14.2 Zosano Pharma Nanotechnology Drug Delivery Systems Product Offered
11.14.3 Zosano Pharma Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.14.4 Zosano Pharma Main Business Overview
11.14.5 Zosano Pharma Latest Developments
11.15 Corium
11.15.1 Corium Company Information
11.15.2 Corium Nanotechnology Drug Delivery Systems Product Offered
11.15.3 Corium Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.15.4 Corium Main Business Overview
11.15.5 Corium Latest Developments
11.16 Nanopass Technologies
11.16.1 Nanopass Technologies Company Information
11.16.2 Nanopass Technologies Nanotechnology Drug Delivery Systems Product Offered
11.16.3 Nanopass Technologies Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.16.4 Nanopass Technologies Main Business Overview
11.16.5 Nanopass Technologies Latest Developments
11.17 Lohmann Therapie-Systeme AG
11.17.1 Lohmann Therapie-Systeme AG Company Information
11.17.2 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Product Offered
11.17.3 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.17.4 Lohmann Therapie-Systeme AG Main Business Overview
11.17.5 Lohmann Therapie-Systeme AG Latest Developments
11.18 Valeritas
11.18.1 Valeritas Company Information
11.18.2 Valeritas Nanotechnology Drug Delivery Systems Product Offered
11.18.3 Valeritas Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.18.4 Valeritas Main Business Overview
11.18.5 Valeritas Latest Developments
11.19 Becton-Dickinson_BD_Technologies
11.19.1 Becton-Dickinson_BD_Technologies Company Information
11.19.2 Becton-Dickinson_BD_Technologies Nanotechnology Drug Delivery Systems Product Offered
11.19.3 Becton-Dickinson_BD_Technologies Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.19.4 Becton-Dickinson_BD_Technologies Main Business Overview
11.19.5 Becton-Dickinson_BD_Technologies Latest Developments
11.20 Vaxxas
11.20.1 Vaxxas Company Information
11.20.2 Vaxxas Nanotechnology Drug Delivery Systems Product Offered
11.20.3 Vaxxas Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.20.4 Vaxxas Main Business Overview
11.20.5 Vaxxas Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Nanotechnology Drug Delivery Systems Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Nanotechnology Drug Delivery Systems Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Nanotechnology Drug Delivery Systems Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Global Nanotechnology Drug Delivery Systems Market Size by Regions, 2015-2025 ($ millions)
Table 7. Global Nanotechnology Drug Delivery Systems Market Size Share by Regions, 2015-2025
Table 8. Global Nanotechnology Drug Delivery Systems Revenue by Player, 2018-2020E ($ millions)
Table 9. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Player, 2018-2020E
Table 10. Global Key Nanotechnology Drug Delivery Systems Players Rank in 2019, Based on the Revenue in Nanotechnology Drug Delivery Systems
Table 11. Global Key Nanotechnology Drug Delivery Systems Players Head office and Products Offered
Table 12. Nanotechnology Drug Delivery Systems Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
Table 13. New Products and Potential Entrants
Table 14. Mergers & Acquisitions, Expansion
Table 15. Major Players of Nanocrystals
Table 16. Major Players of Nanoparticles
Table 17. Major Players of Dendrimers
Table 18. Major Players of Gold Nanoparticles
Table 19. Major Players of Fullerenes
Table 20. Major Players of Liposomes
Table 21. Major Players of Nanotubes
Table 22. Major Players of Others
Table 23. Global Nanotechnology Drug Delivery Systems Market Size CAGR by Type ($ millions): 2015 VS 2020 VS 2025
Table 24. Global Nanotechnology Drug Delivery Systems Market Size by Type, 2015-2025 ($ millions)
Table 25. Global Nanotechnology Drug Delivery Systems Market Size Share by Type, 2015-2025
Table 26. Global Nanocrystals Market Size by Region, 2015-2025 ($ millions)
Table 27. Global Nanocrystals Market Size Share by Region, 2015-2025
Table 28. Global Nanoparticles Market Size by Region, 2015-2025 ($ millions)
Table 29. Global Nanoparticles Market Size Share by Region, 2015-2025
Table 30. Global Dendrimers Market Size by Region, 2015-2025 ($ millions)
Table 31. Global Dendrimers Market Size Share by Region, 2015-2025
Table 32. Global Gold Nanoparticles Market Size by Region, 2015-2025 ($ millions)
Table 33. Global Gold Nanoparticles Market Size Share by Region, 2015-2025
Table 34. Global Fullerenes Market Size by Region, 2015-2025 ($ millions)
Table 35. Global Fullerenes Market Size Share by Region, 2015-2025
Table 36. Global Liposomes Market Size by Region, 2015-2025 ($ millions)
Table 37. Global Liposomes Market Size Share by Region, 2015-2025
Table 38. Global Nanotubes Market Size by Region, 2015-2025 ($ millions)
Table 39. Global Nanotubes Market Size Share by Region, 2015-2025
Table 40. Global Others Market Size by Region, 2015-2025 ($ millions)
Table 41. Global Others Market Size Share by Region, 2015-2025
Table 42. Global Nanotechnology Drug Delivery Systems Market Size CAGR by Application ($ millions): 2015 VS 2020 VS 2025
Table 43. Global Nanotechnology Drug Delivery Systems Market Size by Application, 2015-2025 ($ millions)
Table 44. Global Nanotechnology Drug Delivery Systems Market Size Share by Application, 2015-2025
Table 45. Global Immunology Market Size by Region, 2015-2025 ($ millions)
Table 46. Global Immunology Market Size Share by Region, 2015-2025
Table 47. Global Cardiovascular Market Size by Region, 2015-2025 ($ millions)
Table 48. Global Cardiovascular Market Size Share by Region, 2015-2025
Table 49. Global Neurology Market Size by Region, 2015-2025 ($ millions)
Table 50. Global Neurology Market Size Share by Region, 2015-2025
Table 51. Global Oncology Market Size by Region, 2015-2025 ($ millions)
Table 52. Global Oncology Market Size Share by Region, 2015-2025
Table 53. Global Others Market Size by Region, 2015-2025 ($ millions)
Table 54. Global Others Market Size Share by Region, 2015-2025
Table 55. Americas Nanotechnology Drug Delivery Systems Market Size by Country (2015-2020) ($ Millions)
Table 56. Americas Nanotechnology Drug Delivery Systems Market Size Share by Countries (2015-2020)
Table 57. APAC Nanotechnology Drug Delivery Systems Market Size by Region (2015-2020) ($ Millions)
Table 58. APAC Nanotechnology Drug Delivery Systems Market Size Share by Region (2015-2020)
Table 59. Europe Nanotechnology Drug Delivery Systems Market Size by Country (2015-2020) ($ Millions)
Table 60. Europe Nanotechnology Drug Delivery Systems Market Size Share by Country (2015-2020)
Table 61. MENA Nanotechnology Drug Delivery Systems Market Size by Country (2015-2020) ($ Millions)
Table 62. MENA Nanotechnology Drug Delivery Systems Market Size Share by Country (2015-2020)
Table 63. Key and Potential Regions of Nanotechnology Drug Delivery Systems
Table 64. Key Application and Potential Industries of Nanotechnology Drug Delivery Systems
Table 65. Key Challenges of Nanotechnology Drug Delivery Systems
Table 66. Key Trends of Nanotechnology Drug Delivery Systems
Table 67. AbbVie, Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 68. AbbVie, Inc. Nanotechnology Drug Delivery Systems Product Offered
Table 69. AbbVie, Inc. Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 70. AbbVie, Inc. Main Business
Table 71. AbbVie, Inc. Latest Developments
Table 72. 3M Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 73. 3M Nanotechnology Drug Delivery Systems Product Offered
Table 74. 3M Main Business
Table 75. 3M Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 76. 3M Latest Developments
Table 77. Amgen Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 78. Amgen Inc. Nanotechnology Drug Delivery Systems Product Offered
Table 79. Amgen Inc. Main Business
Table 80. Amgen Inc. Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 81. Amgen Inc. Latest Developments
Table 82. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 83. Johnson & Johnson Nanotechnology Drug Delivery Systems Product Offered
Table 84. Johnson & Johnson Main Business
Table 85. Johnson & Johnson Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 86. Johnson & Johnson Latest Developments
Table 87. Merck & Co., Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 88. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Product Offered
Table 89. Merck & Co., Inc. Main Business
Table 90. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 91. Merck & Co., Inc. Latest Developments
Table 92. Celgene Corporation Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 93. Celgene Corporation Nanotechnology Drug Delivery Systems Product Offered
Table 94. Celgene Corporation Main Business
Table 95. Celgene Corporation Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 96. Celgene Corporation Latest Developments
Table 97. Pfizer, Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 98. Pfizer, Inc. Nanotechnology Drug Delivery Systems Product Offered
Table 99. Pfizer, Inc. Main Business
Table 100. Pfizer, Inc. Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 101. Pfizer, Inc. Latest Developments
Table 102. Novartis International AG Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 103. Novartis International AG Nanotechnology Drug Delivery Systems Product Offered
Table 104. Novartis International AG Main Business
Table 105. Novartis International AG Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 106. Novartis International AG Latest Developments
Table 107. Teva Pharmaceutical Industries Ltd. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 108. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Product Offered
Table 109. Teva Pharmaceutical Industries Ltd. Main Business
Table 110. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 111. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 112. Perrigo Company plc Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 113. Perrigo Company plc Nanotechnology Drug Delivery Systems Product Offered
Table 114. Perrigo Company plc Main Business
Table 115. Perrigo Company plc Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 116. Perrigo Company plc Latest Developments
Table 117. Nitto Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 118. Nitto Nanotechnology Drug Delivery Systems Product Offered
Table 119. Nitto Main Business
Table 120. Nitto Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 121. Nitto Latest Developments
Table 122. TheraJect Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 123. TheraJect Nanotechnology Drug Delivery Systems Product Offered
Table 124. TheraJect Main Business
Table 125. TheraJect Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 126. TheraJect Latest Developments
Table 127. Microdermics Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 128. Microdermics Nanotechnology Drug Delivery Systems Product Offered
Table 129. Microdermics Main Business
Table 130. Microdermics Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 131. Microdermics Latest Developments
Table 132. Zosano Pharma Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 133. Zosano Pharma Nanotechnology Drug Delivery Systems Product Offered
Table 134. Zosano Pharma Main Business
Table 135. Zosano Pharma Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 136. Zosano Pharma Latest Developments
Table 137. Corium Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 138. Corium Nanotechnology Drug Delivery Systems Product Offered
Table 139. Corium Main Business
Table 140. Corium Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 141. Corium Latest Developments
Table 142. Nanopass Technologies Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 143. Nanopass Technologies Nanotechnology Drug Delivery Systems Product Offered
Table 144. Nanopass Technologies Main Business
Table 145. Nanopass Technologies Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 146. Nanopass Technologies Latest Developments
Table 147. Lohmann Therapie-Systeme AG Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 148. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Product Offered
Table 149. Lohmann Therapie-Systeme AG Main Business
Table 150. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 151. Lohmann Therapie-Systeme AG Latest Developments
Table 152. Valeritas Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 153. Valeritas Nanotechnology Drug Delivery Systems Product Offered
Table 154. Valeritas Main Business
Table 155. Valeritas Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 156. Valeritas Latest Developments
Table 157. Becton-Dickinson_BD_Technologies Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 158. Becton-Dickinson_BD_Technologies Nanotechnology Drug Delivery Systems Product Offered
Table 159. Becton-Dickinson_BD_Technologies Main Business
Table 160. Becton-Dickinson_BD_Technologies Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 161. Becton-Dickinson_BD_Technologies Latest Developments
Table 162. Vaxxas Details, Company Total Revenue (in $ million), Head Office, Nanotechnology Drug Delivery Systems Major Market Areas and Its Competitors
Table 163. Vaxxas Nanotechnology Drug Delivery Systems Product Offered
Table 164. Vaxxas Main Business
Table 165. Vaxxas Nanotechnology Drug Delivery Systems Revenue ($ million) and YoY Growth, 2018-2020E
Table 166. Vaxxas Latest Developments
List of Figures
Figure 1. Nanotechnology Drug Delivery Systems Report Years Considered
Figure 2. Global Nanotechnology Drug Delivery Systems Market Size Growth Rate, 2015-2025 ($ millions)
Figure 3. Nanotechnology Drug Delivery Systems Consumption by Region (2015 VS 2020 & 2025) ($ millions)
Figure 4. Global Nanotechnology Drug Delivery Systems Market Size Share by Regions, 2015-2025
Figure 5. Americas Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 6. APAC Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 7. Europe Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 8. MENA Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 9. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Player in 2019
Figure 10. Global Nanotechnology Drug Delivery Systems Market Size Share by Type in 2019
Figure 11. Nanotechnology Drug Delivery Systems in Immunology
Figure 12. Global Nanotechnology Drug Delivery Systems Market Size YoY Growth: Immunology, 2015-2025 ($ millions)
Figure 13. Nanotechnology Drug Delivery Systems in Cardiovascular
Figure 14. Global Nanotechnology Drug Delivery Systems Market Size YoY Growth: Cardiovascular, 2015-2025 ($ millions)
Figure 15. Nanotechnology Drug Delivery Systems in Neurology
Figure 16. Global Nanotechnology Drug Delivery Systems Market Size YoY Growth: Neurology, 2015-2025 ($ millions)
Figure 17. Nanotechnology Drug Delivery Systems in Oncology
Figure 18. Global Nanotechnology Drug Delivery Systems Market Size YoY Growth: Oncology, 2015-2025 ($ millions)
Figure 19. Nanotechnology Drug Delivery Systems in Others
Figure 20. Global Nanotechnology Drug Delivery Systems Market Size YoY Growth: Others, 2015-2025 ($ millions)
Figure 21. Americas Nanotechnology Drug Delivery Systems Value Market Share by Country in 2019
Figure 22. United States Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 23. Canada Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 24. Mexico Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 25. Brazil Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 26. APAC Nanotechnology Drug Delivery Systems Value Market Share by Region in 2019
Figure 27. China Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 28. Japan Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 29. Korea Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 30. Taiwan Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 31. India Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 32. Australia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 33. Indonesia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 34. Thailand Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 35. Malaysia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 36. Philippines Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 37. Vietnam Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 38. Europe Nanotechnology Drug Delivery Systems Value Market Share by Country in 2019
Figure 39. Germany Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 40. France Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 41. UK Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 42. Russia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 43. Italy Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 44. Australia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 45. Benelux Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 46. Nordic Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 47. MENA Nanotechnology Drug Delivery Systems Value Market Share by Country in 2019
Figure 48. Saudi Arabia Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 49. UAE Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 50. Turkey Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 51. South Africa Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
Figure 52. Egypt Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)